Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.
about
Regional and temporal variation in the treatment of rheumatoid arthritis across the UK: a descriptive register-based cohort studyClinical and demographic factors associated with change and maintenance of disease severity in a large registry of patients with rheumatoid arthritis.High disease activity may not be sufficient to escalate careUnderstanding how patients (vs physicians) approach the decision to escalate treatment: a proposed conceptual model.Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis.Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations.Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohortPractice what you preach? An exploratory multilevel study on rheumatoid arthritis guideline adherence by rheumatologists.Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis.Implementation of Treat to Target for Rheumatoid Arthritis in the US: Analysis of Baseline Data from the TRACTION Trial.Rheumatoid arthritis patients' motivations for accepting or resisting disease-modifying antirheumatic drug treatment regimens.bDMARD Dose Reduction in Rheumatoid Arthritis: A Narrative Review with Systematic Literature Search.Implementation of treat-to-target in rheumatoid arthritis through a Learning Collaborative: Rationale and design of the TRACTION trial.Incentives in Rheumatology: the Potential Contribution of Physician Responses to Financial Incentives, Public Reporting, and Treatment Guidelines to Health Care Sustainability.Choosing wisely in daily practice: a mixed methods study on determinants of antinuclear antibody testing by rheumatologists.Timing and impact of decisions to adjust disease-modifying antirheumatic drug therapy for rheumatoid arthritis patients with active disease.Implementation of protocolized tight control and biological dose optimization in daily clinical practice: results of a pilot study.Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial.Factors associated with use of disease modifying agents for rheumatoid arthritis in the National Hospital and Ambulatory Medical Care Survey.A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States.Benefits and Sustainability of a Learning Collaborative for Implementation of Treat to Target in Rheumatoid Arthritis: Results of the TRACTION Trial Phase II.Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry.
P2860
Q28710161-0D0EF9BF-A5C7-476E-8BAE-71BAEA9AB3A1Q33608688-CE1F05EE-8A41-42BC-83D6-AC54D92A01DCQ33812321-73AA025A-273C-4AB6-ADD0-DF6825DED200Q34994608-C18DA6D4-5B08-4417-8E8C-79E0791AE20EQ36456822-C7108ACA-C777-4074-850B-CE8C93414171Q36836531-4BCC30E4-A3A6-4C9C-B0B2-FDA0B629AF2AQ36907691-48BB521A-6CE9-4360-A967-AC778A57B5C4Q36933286-91DAA66D-D78F-429D-9F59-1EE7CCE0BF8BQ36942985-10C9EB9F-BD28-4135-B637-5515F4011FE0Q38611683-853FDF2F-3ED1-48D1-9455-7A7218AB286DQ38675559-338FEA22-6728-4818-9695-C68581EACEB2Q38751251-E7AFC0FB-963B-4175-8478-26228B581C3AQ38802166-1EA222A3-6D0A-4555-AA86-763936E78E3CQ38848203-CCF13BF8-077C-4FD1-B5D5-DA6F076C88EBQ39546255-7216CBCB-EF8A-44A6-9B2D-45A32B18B232Q47262286-7B7366D6-19A3-469D-B685-ADE279009AD3Q48035875-7DB07DF1-14A8-4F38-BA87-B311046AF236Q48133644-82DA2075-AF14-4C85-A45A-6C058EDC5568Q49886510-DC907673-6180-4D55-BEA3-98D16890F339Q50076043-ADED078C-FF27-484F-B817-F25B1A178E57Q50117296-A1712C19-ACF4-4870-B51E-0F588D331AAAQ55086137-7CECDA5C-9D13-4DB6-A31B-CEB40C7E6648
P2860
Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prescribing practices in a US ...... ogy treatment recommendations.
@ast
Prescribing practices in a US ...... ogy treatment recommendations.
@en
type
label
Prescribing practices in a US ...... ogy treatment recommendations.
@ast
Prescribing practices in a US ...... ogy treatment recommendations.
@en
prefLabel
Prescribing practices in a US ...... ogy treatment recommendations.
@ast
Prescribing practices in a US ...... ogy treatment recommendations.
@en
P2093
P2860
P356
P1476
Prescribing practices in a US ...... ogy treatment recommendations.
@en
P2093
Daniel E Furst
George Reed
J Timothy Harrington
Jeffrey D Greenberg
Jeffrey R Curtis
Joel Kremer
Leslie R Harrold
Mary Jane Bentley
P2860
P304
P356
10.1002/ART.33380
P577
2012-03-01T00:00:00Z